SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-22-029969
Filing Date
2022-08-17
Accepted
2022-08-17 09:02:17
Documents
1
Effectiveness Date
2022-08-17

Document Format Files

Seq Description Document Type Size
1 S-8 POS brhc10040737_s8pos.htm S-8 POS 21876
  Complete submission text file 0001140361-22-029969.txt   23091
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-237250 | Film No.: 221172212
SIC: 2834 Pharmaceutical Preparations